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Abstract Stable isotope tracers have been invaluable assets in physiological research for over
80 years. The application of substrate-specific stable isotope tracers has permitted exquisite insight
into amino acid, fatty-acid and carbohydrate metabolic regulation (i.e. incorporation, flux, and
oxidation, in a tissue-specific and whole-body fashion) in health, disease and response to acute
and chronic exercise. Yet, despite many breakthroughs, there are limitations to ‘substrate-specific’
stable isotope tracers, which limit physiological insight, e.g. the need for intravenous infusions
and restriction to short-term studies (hours) in controlled laboratory settings. In recent years
significant interest has developed in alternative stable isotope tracer techniques that overcome
these limitations, in particular deuterium oxide (D2O or heavy water). The unique properties
of this tracer mean that through oral administration, the turnover and flux through a number
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of different substrates (muscle proteins, lipids, glucose, DNA (satellite cells)) can be monitored
simultaneously and flexibly (hours/weeks/months) without the need for restrictive experimental
control. This makes it uniquely suited for the study of ‘real world’ human exercise physio-
logy (amongst many other applications). Moreover, using D2O permits evaluation of turnover
of plasma and muscle proteins (e.g. dynamic proteomics) in addition to metabolomics (e.g.
fluxomics) to seek molecular underpinnings, e.g. of exercise adaptation. Here, we provide insight
into the role of stable isotope tracers, from substrate-specific to novel D2O approaches, in
facilitating our understanding of metabolism. Further novel potential applications of stable
isotope tracers are also discussed in the context of integration with the snowballing field of ‘omic’
technologies.
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Abstract figure legend Contemporary stable isotope approaches coupled to mass spectrometry can now provide
synchronous insights into the dynamics of acute and chronic metabolism (e.g. protein, nucleic acid, energy production
and storage, andmetabolic pathway flux) in the contexts of end-points relating to the physiological, clinical, performance
and health benefits of exercise.
Abbreviations AA, amino acid; D2O, deuterium oxide; EAA, essential amino acid; FSR, fractional synthetic rate; I.V.,
intravenous; LC-MS/MS, liquid chromatography tandem mass spectrometry; 3-MH, 3-methylhistidine; MPB, muscle
protein breakdown; MPS, muscle protein synthesis; MRI, magnetic resonance imaging; Ra, rate of appearance; Rd, rate
of disappearance; RET, resistance exercise training.
What are stable isotope tracers and how are they
applied in studies?
An isotope is a species of an element that differs in mass
through the addition of one or more neutrons within the
atomic nucleus; while naturally occurring they are far less
abundant than their more common lighter isotopes. This
difference in mass permits these isotopes to be detected,
generally using the technique of mass spectrometry – a
mass spectrometer separates atoms or molecules based
on their mass and/or charge (after undergoing some
form of ionization) as they pass through an electrical
and/ormagnetic fieldunder vacuum; they are traditionally
combined with chromatographic (gas chromatography or
liquid chromatography) separation techniques, to permit
the separation of complexmixtures of organic compounds
prior to detection in the mass spectrometer. There are two
forms of isotopic tracers: radio-isotope tracers (e.g. 14C
and 3H (tritium)) are radioactive and therefore potentially
harmful; their use is now largely restricted to animal
rather than human experiments. Stable isotope tracers
(e.g. 18O, 15N, 13Cand 2H) in contrast, arenon-radioactive,
making them ideal for use in human research. Crucially,
the chemistry of these elements and the compounds into
which they are incorporated is essentially the same as that
of the endogenous ones. As such, they can be used to
‘trace’ metabolic flux in pathways of interest and the fate
of the tracer can be monitored (via its mass difference),
providing vital information regarding rates and extent of
its metabolism.
Stable isotope tracers are typically substrate specific.
That is, stable isotopically labelled amino acids (AAs)
provide information on amino acid and protein
metabolism, labelled fatty acids will inform on fat meta-
bolism, while glucose tracers will reflect carbohydrate
metabolism and storage. Application of these tracers
has been instrumental in yielding information on (1)
the synthesis of polymers (i.e. proteins (Rennie et al.
1982; Halliday et al. 1988), triglycerides (Guo & Jensen,
1998) and glycogen (Romijn et al. 1993), (2) substrate
uptake, release and intermediary metabolism across or
within organs and tissues using arterial–venous balance
techniques (Biolo et al. 1994), (3) substrate oxidation
(Phillips et al. 1996) and energy expenditure (Goran et al.
1990), and (4) whole body and tissue/organ-specific fuel
metabolism (Rennie&Halliday, 1984). In termsof exercise
physiology, these stable isotope tracer approaches have
assisted in detailing the complex metabolic responses of
tissues to exercise. Some of themost important discoveries
include the delineation of protein synthetic and break-
down responses to exercise, i.e. when performed in the
absence of nutrition, exercise is catabolic (Biolo et al.
1995; Phillips et al. 1999; Kumar et al. 2009), and that
the essential amino acid (EAA) constituents of food are
the key nutrients supporting exercise-induced increases
in muscle protein synthesis (MPS) (Pennings et al. 2011;
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Burd et al. 2011). Furthermore, the use of stable isotope
tracers has also been key to determining shifts in substrate
utilization and fuel use during exercise, e.g. highlighting
reductions in lipid oxidation at increasing exercise
intensities (Friedlander et al. 2007), and the important
role of endurance training in increasing utilization of
lipids to spare muscle glycogen (Phillips et al. 1996).
To perform traditional stable isotope tracer experiments
requires sterile infusates, intravenous (I.V.) cannulation(s)
and multiple (usually muscle) tissue biopsies. Moreover,
constant I.V. infusions require subjects be studied in a
controlled clinical or laboratory environment – restricting
measures to < 24 h and traditionally over 2–8 h –
and requiring different stable isotope tracers for each
substrate to be ‘measured or traced’ (e.g. [2H2]glucose
for glucose metabolism, [U-13C]palmitate for lipid
metabolism and [1,2,13C2]leucine or [2H5]phenylalanine
for protein metabolism) (Fig. 1). The time limited and
invasive nature of these studies narrows their applications;
moreover acute findings may not always translate into
a chronic setting, e.g. acute postexercise MPS exhibited
no correlation to ensuing skeletal muscle hypertrophy
following resistance exercise training (RET) (Mitchell et al.
2014).
However, despite these limitations, these substrate-
specific tracer techniques have been invaluable to our
understanding of basic human metabolism and its
responses to stress, nutrition, health and disease. The
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Figure 1. Application of substrate-specific stable isotope tracers for measurement of metabolism
Schematic diagram summarizing the typical application of substrate-specific tracers for measuring metabolism,
utilizing both precursor–product and arterial–venous (A-V) balance techniques. A single substrate-specific tracer is
required to be administered for the measurement of turnover of each substrate pool of interest (e.g. glucose
metabolism using [2H2]glucose, lipid metabolism using [U-13C]palmitate and protein/AA metabolism using
[1,2,13C2]leucine). These substrate-specific tracers are usually administered by I.V. infusion and as such are limited
to measurement periods  24 h, but typically < 8 h. Measurement of the rate of disappearance (Rd) of the stable
isotope tracer from the arterial pool provides a proxy for synthesis, while the rate of appearance (Ra) of the tracee
in the venous pools (i.e. via dilution of the tracer) provides that of breakdown. Stable isotope tracers and A-V
balance calculations can therefore provide estimates of both synthesis and breakdown, as well as de novo synthesis
of intermediary metabolites and substrate oxidation across tissues or limbs (when combined with blood flow and
CO2 measurements). Furthermore, the rate of synthesis or incorporation into tissue pools (i.e. protein, glycogen,
lipids) can be measured using the precursor–product approach. By sampling the tissue or pool at two time points
in relation to the precursor enrichment (e.g. AA tracers incorporated into peptides via their corresponding amino
acyl-tRNA) provides a fractional synthesis rate (FSR). ET1, Enrichment in product at time T1; ET2, Enrichment in
product at time T2; Ep, Enrichment in precursor pool.
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findings from these studies continue to provide us with
a wealth of knowledge and mechanistic understanding
of the intricacies of metabolism, and these approaches
will continue to underpin advances in human metabolic
research. It is important to note that with any in vivo
technique, there will be inherent limitations to the
methods and the following sections aim to highlight
new tools that will compliment these traditional tracer
techniques, thereby providing greater insight.
Emerging era of non-substrate-specific stable isotope
tracers
Deuterium oxide (D2O, ‘heavy water’ or 2H2O) was
one of the first stable isotope tracers to be used in
metabolic research, by Schoenheimer (Schoenheimer
& Rittenberg, 1936) and Ussing (1937, 1938, 1941).
Nonetheless, the benefits of D2O as a stable isotope tracer
only really began to be recognized in the late 20th century,
with technical advances in analytical instrumentation
and development of commercially available hybrid MS
(i.e. gas chromatography–pyrolysis–isotope ratio mass
spectrometry and liquid chromatography–tandem mass
spectrometry (LC-MS/MS); Kuksis &Myher, 1995; Begley
& Scrimgeour, 1996). It was soon realized that D2O could
provide an alternative approach and overcome some
of the issues related to the use of traditional substrate-
specific stable isotope tracers (Dufner & Previs, 2003).
Administered orally (Previs et al. 2004; Gasier et al.
2010, 2012; Robinson et al. 2011; MacDonald et al. 2013;
Wilkinson et al. 2014, 2015; Decaris et al. 2015) as a single
bolus (MacDonald et al. 2013; Wilkinson et al. 2014,
2015) or in the form of regular doses (Robinson et al.
2011; Brook et al. 2015; Decaris et al. 2015), D2O rapidly
equilibrates with body water (20 min in rats (Dufner
et al. 2005); 1–2 h in humans (IAEA, 2011)). This creates
a homogeneous labelled precursor pool, which slowly
turns over (half-life 9–11 days; MacDonald et al. 2013;
Wilkinson et al. 2014), thereby overcoming the need
for I.V. stable isotope tracer administration (Dufner &
Previs, 2003). Deuterium from the body water is ex-
changed through biological reductions during de novo
(re)synthesis onto a myriad metabolic substrates at
stable C-H positions, allowing rates of flux and turnover
(synthesis and breakdown) within these substrate
pools to be calculated (Hellerstein, 2004). Thus, unlike
substrate-specific tracer methods, D2O provides an
opportunity for measuring the turnover of multiple
pools simultaneously (Fig. 2), overcoming the need for
an individual stable isotope tracer for each different
substrate pool. For example, deuterium is incorporated
into AAs (traditionally alanine, glutamate or glutamine
is monitored as they can be labelled at multiple carbon
positions; Busch et al. 2006; Herath et al. 2011), allowing
MPS rates to be probed from the incorporation of labelled
AAs into tissue protein (Gasier et al. 2010). In addition
through labelling of individual fatty acids, as well as
glycerol via glucose, lipid turnover can be quantified
(Diraison et al. 1997; Turner et al. 2003; Strawford et al.
2004), whilst labelling by D2O at different steps in de
novo nucleotide synthesis can provide rates of DNA
(and RNA) turnover (Busch et al. 2007; Voogt et al.
2007). Crucially, the relatively slow turnover of the body
water pool permits measurement over longer periods,
i.e. days, weeks or months (Robinson et al. 2011; Gasier
et al. 2012; Wilkinson et al. 2014, 2015; Brook et al.
2015). This permits experiments to be extended beyond
standard limits for traditional stable isotope tracer studies
of 24 h, thereby providing a vital mechanism for
monitoring chronic, cumulative metabolic rates of greater
translational relevance.
Since stable isotope tracers are intended to produce
quantitative metabolic flux data, the validity of D2O
was recently compared against substrate-specific stable
isotope tracers and was validated over hours, days and
weeks. In a preliminary study we quantified MPS using
a single oral D2O bolus alongside the ‘gold-standard’
primed, continuous I.V. infusion of [13C6]phenylalanine
within the same person in both fasted and fed (20 g EAA)
states over 6 h (Wilkinson et al. 2015). D2O provided
comparable mean fractional synthetic rate (FSR) values
to those obtained using the traditional phenylalanine
tracer, in both fasted and fed states, with a comparable
magnitude and direction of change in FSR following
feeding (Wilkinson et al. 2015). Whilst this shows validity
of the technique in a short-term laboratory setting, amajor
benefit of D2O is its potential over longer periods. To
address this, we studied individuals over an 8 day period
incorporating four bouts of unilateral resistance exercise;
in doing so we found that MPS measured with D2O in
the non-exercised leg was equivalent to that normally
reported with AA stable isotope tracer (1.2–1.5% day–1
or 0.05–0.06% h–1). Moreover, the exercised leg exhibited
significantly greater rates of MPS in multiple muscle
protein fractionsover the 8days consistentwith early albeit
‘undetectable’ (i.e. by imaging techniques) muscle hyper-
trophy (Wilkinson et al. 2014). This further highlights
the quantitative validity of the approach while exposing
the capacity to gain insight into muscle protein fraction
(e.g. contractile proteins/mitochondria) regulation on a
long-term basis. Following on from this we conducted
a 6-week RET study and showed that increased MPS
over the first 3 weeks of RET matched early, plateauing
muscle hypertrophy (Brook et al. 2015). Importantly,
in contrast to findings with acute MPS (Mitchell et al.
2014), chronic MPS derived using D2O correlated to
long term muscle hypertrophy due to RET (Brook et al.
2015), suggesting D2O can provide a predictive real life
representation of exercise adaptation – a premise that was
recently confirmed (Damas et al. 2016).
C© 2016 The Authors. The Journal of Physiology C© 2016 The Physiological Society
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As with all tracer techniques, major questions are,
what is the true precursor pool? How do we measure
it? And can we define an appropriate surrogate pre-
cursor? In terms of protein synthesis, the true pre-
cursor pool is the amino acyl-tRNA; however, this pool
is extremely small and labile and difficult to analyse,
and therefore a surrogate that best approximates the
true labelling is often used, for example, venous plasma
α-ketoisocaproate for leucyl-tRNA (Watt et al. 1991)
or intracellular phenylalanine for phenylalanyl-tRNA
(Baumann et al. 1994). With respect to D2O, the rapid
equilibrium throughout the body water pool allows for
efficient exchange onto AA intracellularly, and as long as
the rate of exchange onto the AA is faster than the rate
of turnover of the product (e.g. alanine; Yang et al. 1984),
the assumption is made that the labelling of the surrogate
precursor, intracellular or plasma alanine, reflects that of
the D2O body water labelling (corrected for the number
of potential hydrogens labelled on the AA; Dufner &
Previs, 2003; Gasier et al. 2010). Therefore we can use
body water labelling to determine the true precursor
for the alanyl-tRNA. This assumption seems to hold for
the case of plasma alanine (Dufner et al. 2005; Belloto
et al. 2007), and intracellular alanine (Belloto et al. 2007).
Significant dilutions to the alanine pool (i.e. through
feeding) have been shown to equilibrate rapidly (Dufner
et al. 2005; Belloto et al. 2007). As with many similar
tracer techniques, the assumption is made that tracer
recycling isminimal, particularlywhere the turnover of the
pool is slow, such as in skeletal muscle. In addition with
the rapid exchange of deuterium onto AA, any dilution
through recyclingmaybeovercomeby this rapid exchange.
This, however, is something that needs experimental
confirmation, particularly with studies performed over
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Figure 2. Application of the non-substrate-specific stable isotope tracer D2O for the measurement of
metabolic turnover
Schematic diagram summarizing how D2O can be used as a stable isotope tracer for measuring metabolism of
multiple substrates in vivo. Upon oral administration (avoiding the need for invasive I.V. administration) D2O rapidly
equilibrates with the body water pool and distributes equally throughout all tissues and organs. Deuterium from
the body water is subsequently incorporated into multiple biological substrates such as glucose, AAs and fatty
acids, which, unlike substrate-specific stable isotope tracers, allows for the measurement of turnover of multiple
substrate pools simultaneously. Due to the slow turnover of the body water pool (half-life 9–11 days), D2O
can provide measurement over periods as short as a few hours in duration (a time period typical for the use of
substrate-specific stable isotope tracers) up to days, weeks or even months depending on the substrate of interest
(e.g. muscle protein turns over relatively slowly 1–2% day–1, whereas intramuscular triglycerides turnover at
1–2% h–1) and through maintenance of the precursor pool (D2O in the body water pool) with regular oral
dosing of D2O, highlighting the benefit and additional value that D2O can provide complimentary to traditional
substrate-specific stable isotope tracers.
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longer periods, and groups are beginning to investigate
these modelling assumptions further (Previs et al. 2015;
Zhou et al. 2015).
Beyond protein metabolism, others have been able to
use D2O to track synthesis rates of muscle DNA during
prolongedexercise (Robinson et al.2011), a techniquewith
clear importance due to the controversial role of satellite
cells in exercise adaptation (Gundersen, 2016). The same is
theoretically true for RNA,meaning one can track the role
of ribosomal biogenesis in human exercise adaptation. In
addition, D2O has been used to trace cholesterol (and
other sterols), plasma lipid metabolism (Castro-Perez
et al. 2011), and tissue triglyceride and glucose turnover
(Strawford et al. 2004), e.g. in relation to energy sub-
strate metabolism. Thus, D2O offers a full complement of
tools for providing detailed translational insight into the
metabolic basis of the physiological adaptation to exercise
in both acute and chronic settings.
Stable isotope tracer and D2O ‘omics’: towards a
more mechanistic era
Tissues consist of tens of thousands of proteins and many
more metabolites that perform and regulate different
functions at varying rates. Therefore measures of crudely
fractionated proteins, e.g. sarcoplasmic/myofibrillar
or ‘static’ metabolite abundances, provide limited
information on individual proteins and metabolic fluxes.
To gain insight into this, the recent explosion of systems
biology has led to the combination of stable isotope
tracers/D2O with ‘omics’, particularly metabolomics and
proteomics. For instance, usingD2O ingestion in humans,
Hellerstein et al.devised amethod to isolate peptides using
nanoLC-MS/MSand to quantify enrichment of deuterium
within these peptides to calculate rates of turnover for
individual proteins (Price et al. 2012). Unsurprisingly,
despite their infancy, these methods are rapidly being
utilized to provide unique information regarding tissue
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Figure 3. D2O and stable isotope tracer ‘omics’
Summary of how D2O and substrate-specific stable isotope tracers can be used in conjunction with omics
techniques (proteomics and metabolomics) for measuring the turnover of individual proteins and the rates of
flux through individual metabolic pathways (fluxomics) in vivo. Proteomics: bulk tissue protein is made up of
thousands of individual proteins that have varying functions and turnover rates; using AA stable isotope tracers
and D2O alongside novel nanoLC-MS/MS techniques, the rates of turnover of individual proteins can be determined
by looking for incorporation of isotopic label into isolated peptides. This will provide a more holistic insight into the
regulation of tissue protein to interventions such as exercise. Fluxomics: complimentary to this, using metabolomics
in conjunction with stable isotope tracers or D2O the flux of metabolites through different metabolic pathways can
be measured, by monitoring the level of isotopic labelling in downstreammetabolites. This will provide information
on rates of flux through these metabolic pathways, an application particularly suited to exercise physiology where
substrate fluxes will dynamically alter in response to different intensities, modes and durations of exercise. M0-M2
represents the mass isotopomer distribution.
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proteome dynamics in response to exercise. For example,
Shankaran and colleagues were able to quantify FSRs for
273 individual muscle proteins in response to 3 weeks
of sprint interval training, and highlight the distinct
inter-individual differences in FSR responses for each
individual’s proteome, suggestive that exercise responses
are highly specific to each individual (Shankaran et al.
2016). Moreover, using these techniques the notion of
a ‘virtual muscle biopsy’ has been described. Using
D2O-led dynamic proteomics, plasma proteins, such
as the muscle-specific creatine kinase and carbonic
anhydrase 3 accurately represented rates of turnover of
the same proteins (or crude fractions) sampled from
muscle (Shankaran et al. 2016). This could prove useful in
situations where muscle biopsies may be contraindicated,
such as in young children or frail elderly, or where they are
not easily obtainable such as during exercise.
Alongside novel proteomics, the emerging application
of stable isotope tracers in metabolomics now enables
‘fluxomics’ (Fig. 3), whereby flux through metabolic
pathways can be dynamicallymonitored (Niedenfu¨hr et al.
2014). A recent example of this was provided in an
outbred rat model selected for high or low intrinsic or
inborn aerobic capacity (Overmyer et al. 2015). Using a
[U-13C,15N]valine tracer, and monitoring the enrichment
of 13C labelling in downstream metabolites of valine
such as C3/C4 carnitines and β-hydroxyisobutyrate, and
the 15N labelling of transamination metabolites such as
glutamate, it was shown that high aerobic capacity was
associated with increased flux through branched chain
amino acid catabolic pathways, which combined with
more efficient fatty acid utilization sparedmuscle glycogen
(Overmyer et al. 2015). These fluxomics techniques
could become even more powerful when combined with
novel tracers such as D2O, which has the potential to
provide flux data from a multitude of different pathways
simultaneously (through mechanisms described above
(Fig. 3). Enabling energy substrate flux to be dynamically
probed in an unbiased manner will be key to exercise
physiology research as it can provide dynamic metabolic
data in response to interventions such as exercise and
diet, e.g. to quantify the mechanisms of energy sub-
strate contributions to exercise. Whilst these techniques
are still in their infancy, the application of dynamic
proteomics andmetabolomics alongside traditional ‘bulk’
metabolic tracer studies will provide tools to develop a
more integrated and holistic understanding of physio-
logical and health adaptations to exercise. It is noteworthy
that all are indeed eminently doable in humans.
Emerging non-invasive stable isotope tracer
techniques: muscle protein breakdown and mass
Quantification of 3-methylhistidine (3-MH) in urine (a
post-translationallymodifiedhistidine residue that cannot
be reincorporated into new peptides following break-
down) has been used as a proxy for muscle protein
breakdown (MPB) for > 40 years (Bilmazes et al. 1978).
Nonetheless, its abundance is very low, routinely being
measured through 24 h urine collections, and it can be
affected by dietary (meat) intake thereby influencing its
accuracy (Marliss et al. 1979). However, via oral provision
of 2H3-labelled 3-MH andmonitoring its dilution by end-
ogenously released 3-MH in temporal blood or urine
samples, a rate of whole body myofibrillar protein break-
down can be estimated in an approach that is not
significantly influenced by diet (Sheffield-Moore et al.
2014). Therefore, this provides a future opportunity to
investigate the ‘missing part of the balance equation’
(most people tend to look only at MPS due to technical
challenges ofmeasuringMPB) andhowMPB ismodulated
by exercise or nutritional interventions.
The quantification of whole body skeletal muscle mass,
for example, typically requires expensive imaging tech-
nology (magnetic resonance imaging (MRI), computer
tomography, dual-energy X-ray absorptiometry). How-
ever, it was recently shown that whole body muscle mass
could be determined by measuring the enrichment of
[2H3]creatinine in the urine following provision of a small
oral bolus of [2H3]creatine; oral [2H3]creatine equilibrates
within the muscle creatine pool, is converted to creatinine
at a constant rate of 2% day–1 and excreted in urine,
where the enrichment of [2H3]creatinine in the urine is
representative of [2H3]creatine enrichment in the muscle.
From this, creatine pool size and skeletal muscle mass
can be estimated (Stimpson et al. 2012, 2013; Clark et al.
2014). While not a new technique (Kreisberg et al. 1970;
Picou et al. 1976), this has since been validated providing
accurate measures of whole body skeletal muscle which
correlate withMRImeasures in humans (Clark et al. 2014)
and changes inmusclemass in growing animals (Stimpson
et al. 2013).
Conclusions: the future
Substrate-specific stable isotope tracers have provided
great insight into protein, lipid and carbohydrate meta-
bolism responses to acute/chronic exercise. Recent
developments of novel stable isotope tracer techniques
mean it is now possible to use a single non-substrate-
specific tracer, D2O, to measure the turnover of multiple
substrate pools simultaneously in ‘free living’ humans over
hours to months, overcoming limitations associated with
substrate-specific tracers. When applied in conjunction
with proteomics and metabolomics, D2O has the power
to probe metabolism down to the level of the turnover
of single proteins or flux through metabolic pathways.
The combination of traditional substrate-specific stable
isotope tracers for measurement of acute tissue-specific
and whole body metabolism and D2O for chronic ‘free
C© 2016 The Authors. The Journal of Physiology C© 2016 The Physiological Society
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living’ measurements of multiple substrate turnover,
single protein turnover and flux, alongside other mini-
mally invasive stable isotope tracer techniques (e.g. MPB
and muscle mass), means that in the future we can
provide in humans a dynamic holistic picture of exercise
metabolism in the minutest detail.
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